A Preliminary Look at Subtyping People With Type 2 Diabetes

Type 2 diabetes subtyping offers a paradigm shift from traditional diagnostic frameworks, moving clinicians away from a one-size-fits-all approach to glucose management. In this educational resource, Anne L. Peters, MD discusses data from a landmark Swedish cohort study that classifies patients into distinct physiological categories to better predict long-term clinical outcomes. The presentation outlines five distinct diabetes subtypes identified in the All New Diabetics in Scania (ANDIS) study: severe autoimmune diabetes, severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes, and mild age-related diabetes. Understanding these classifications allows medical professionals to identify which patients face the highest risk for specific diabetic complications—such as retinopathy, neuropathy, chronic kidney disease, and cardiovascular events. By analyzing underlying drivers like insulin resistance and insulin deficiency, this research provides a foundational framework for implementing personalized medicine and tailored risk-reduction strategies in clinical practice. 00:00 - Introduction to Diabetes Subtyping 00:25 - Overview of the ANDIS Cohort Study 01:36 - Study Methodology and Key Variables 02:40 - The Five Subtypes of Type 2 Diabetes 03:58 - Complication Risks for Insulin-Deficient Subtypes 04:34 - Complication Risks for Insulin-Resistant Subtypes 07:47 - Clinical Implications for Personalized Diabetes Care https://www.medscape.com/viewarticle/...